Prospective Study Of Efficacy And Perinatal Outcome Of Hydrotherapy In Oligohydroamnios Patients

Abstract

Background: Oligohydramnios means a low level of amniotic fluid during pregnancy. It is defined by an amniotic fluid index that is below 5th percentile for the gestational age. It may cause IUGR, fetal anomalies, mal presentations and fetal distress in labour. Oral or intravenous fluid therapy may increase the amount of amniotic fluid and may improve perinatal outcome. Aims And Objectives: To study efficacy and perinatal outcome of hydrotherapy in patients with oligohydamnios. Material & Methods: A prospective observational study was carried out at tertiary care centre for 6 months. 30 cases of oligohydramnios were enrolled in this study. Results: In present study, maximum (50%) patients admitted for oligohydramnios were between 28 – 32 weeks gestational age and 66% were having severe oligohydramnios. After giving hydration therapy, difference in AFI, was 2.57±0.13, which was statistically significant. 83.3% patients were delivered after 36 weeks and 80% were delivered by normal vaginal delivery. 53.3% babies were live healthy, whereas others needed resuscitation and admitted to NICU. Conclusion: Oligohydramnios has higher impact on perinalal outcome due to antenatal and intrapartum complication. Because of early diagnosis by ultrasonography or clinical analysis, fluid therapy is an option to increase amniotic fluid volume and so perinatal outcome may be improved. [Patel P Natl J Integr Res Med, 2021; 12(1):36-41]